InvestorsHub Logo
icon url

reaper247

10/18/18 1:13 AM

#18641 RE: steadyhand #18632

Hey there steadyhand, absolutely.

Oncolix will be at 50 cents by next year. Wait and see....



300,000 shares of ONCX at a cost basis average of .02 is $6,000.

With a historical ONCX bottom of roughly .01, the potential loss would be around $3,000.

300,000 shares that bounce to the previous high of $.20 would be $60,000.

With the conservative target price of .50, if FDA results are positive, would result in 300,000 ONCX shares being worth $150,000.

How many times have we discussed risk/reward ratios on the ONCX board?

I actually enjoy the ONCX debate and jibber/jabber.

Seriously though, we are looking at a $3,000 VAR against a potential $140,000 ROI.

Investors will probably not see odds like this again anytime soon on any OTC stock and it is shocking that people continue to squander this opportunity.

C'est la vie.

IMO and FWIW.
icon url

DayDreeming

01/28/19 1:42 PM

#19105 RE: steadyhand #18632

LOL!!!!!!

So the GHS who has invested millions is going to dump their 117 million shares at 300 bucks a day?

Wow who will they have making those 300 dollar trades? The CEO????


Hahaha GLTU.....


Oncolix will be at 50 cents by next year. Wait and see....